ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.4714C>T (p.Arg1572Ter)

dbSNP: rs1554008881
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000599182 SCV000709862 uncertain significance not specified 2015-07-02 criteria provided, single submitter clinical testing The R1572X variant in the TTN gene has not been reported as a pathogenic variant or as a benign polymorphism to our knowledge. R1572X is predicted to cause loss of normal protein function either by protein truncation or nonsense-mediated mRNA decay. Additionally, the R1572X variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. However, other truncating TTN variants have been reported in approximately 3% of control alleles (Herman D et al., 2012). Furthermore, R1572X is not located in the A-band region of titin, where the majority of truncating mutations associated with DCM have been reported (Herman D et al., 2012).Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant.
Klaassen Lab, Charite University Medicine Berlin RCV002062110 SCV002495735 likely pathogenic Left ventricular noncompaction cardiomyopathy criteria provided, single submitter research
Ambry Genetics RCV002341535 SCV002636225 uncertain significance Cardiovascular phenotype 2022-05-23 criteria provided, single submitter clinical testing The p.R1526* variant (also known as c.4576C>T), located in coding exon 25 of the TTN gene, results from a C to T substitution at nucleotide position 4576. This changes the amino acid from an arginine to a stop codon within coding exon 25. This exon is located in the near Z-disk region of the N2-B isoform of the titin protein and is constitutively expressed in TTN transcripts (percent spliced in or PSI 100%). This variant (referred to as NM_001267550.1:c.4714C>T p.R1572*) has been detected in a left ventricular noncompaction cardiomyopathy cohort (Schultze-Berndt A et al. Front Pediatr, 2021 Sep;9:722926). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Truncating variants in the A-band of titin are the most common cause of dilated cardiomyopathy (DCM), and, regardless of their position, truncating variants encoded in constitutive exons (PSI >90%) have been found to be significantly associated with DCM (Herman DS et al. N. Engl. J. Med., 2012 Feb;366:619-28; Roberts AM et al. Sci Transl Med, 2015 Jan;7:270ra6; Schafer S et al. Nat. Genet., 2017 01;49:46-53). However, TTN truncating variants have also been reported in 1-3% of the general population (Herman DS et al. N. Engl. J. Med. 2012;366:619-28). Based on available evidence to date, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.